$6.11 Billion is the total value of OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s 384 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 6.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AEGERIONnote2 | $20,800,000,000 | +0.6% | 26,000,000 | 0.0% | 0.34% | -2.6% | ||
| CPAAU | CONYERSunit9 | $12,750,000,000 | +13.6% | 1,000,000 | 0.0% | 0.21% | +10.6% | |
| HDS | HD SUPPL | $11,486,000,000 | -25.5% | 375,000 | 0.0% | 0.19% | -27.7% | |
| OREXIGENnote2 | $3,000,000,000 | 0.0% | 7,500,000 | 0.0% | 0.05% | -3.9% | ||
| OREXIGENnote2 | $3,000,000,000 | 0.0% | 7,500,000 | 0.0% | 0.05% | -3.9% | ||
| ROST | ROSS STO | $1,443,000,000 | -12.4% | 25,000 | 0.0% | 0.02% | -14.3% | |
| CITRIX Snote0 | $1,203,000,000 | -4.4% | 1,000,000 | 0.0% | 0.02% | -4.8% | ||
| LIBERTYnote1 | $1,189,000,000 | +4.7% | 1,000,000 | 0.0% | 0.02% | 0.0% | ||
| PRICELINnote0 | $1,148,000,000 | +1.9% | 1,000,000 | 0.0% | 0.02% | 0.0% | ||
| BIOMARINnote0 | $1,113,000,000 | -1.9% | 1,000,000 | 0.0% | 0.02% | -5.3% | ||
| ILLUMINAnote6 | $1,015,000,000 | +0.4% | 1,000,000 | 0.0% | 0.02% | 0.0% | ||
| INTERCEPnote3 | $978,000,000 | +4.4% | 1,000,000 | 0.0% | 0.02% | 0.0% | ||
| NUANCE Cdbcv1 | $969,000,000 | +1.3% | 1,000,000 | 0.0% | 0.02% | 0.0% | ||
| TWITTERnote0 | $949,000,000 | +0.5% | 1,000,000 | 0.0% | 0.02% | 0.0% | ||
| GCVRZ | SANOFIright | $470,000,000 | -15.6% | 1,238,077 | 0.0% | 0.01% | -11.1% | |
| CYHHZ | COMMUNITright | $99,000,000 | +130.2% | 5,055,677 | 0.0% | 0.00% | +100.0% | |
| OREXQ | OREXIGEN | $0 | – | 33,333 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| META PLATF | 36 | Q3 2023 | 2.3% |
| SPDR S&P 5 | 33 | Q3 2023 | 0.7% |
| ACTIVISION | 29 | Q3 2023 | 71.3% |
| AMAZON COM | 29 | Q3 2023 | 0.8% |
| GAMING & L | 29 | Q3 2023 | 0.8% |
| SPDR S&P | 29 | Q1 2023 | 0.1% |
| DISNEY W | 28 | Q3 2021 | 2.0% |
| POST HLD | 27 | Q2 2020 | 1.8% |
| GENERAL | 27 | Q3 2022 | 1.4% |
| CAMDEN PPT | 27 | Q3 2023 | 0.6% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/Sold out | February 13, 2023 | 0 | 0.0% |
| MAGELLAN HEALTH INCSold out | February 13, 2023 | 0 | 0.0% |
| New Providence Acquisition Corp. II | February 13, 2023 | 2,227,500 | 8.9% |
| Nuance Communications, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| SCP & CO Healthcare Acquisition CoSold out | February 13, 2023 | 0 | 0.0% |
| ACORDA THERAPEUTICS INCSold out | February 14, 2022 | 0 | 0.0% |
| Amryt Pharma plc | February 14, 2022 | 9,950,000 | 3.1% |
| Evolv Technologies Holdings, Inc. | February 14, 2022 | 1,547,311 | 1.1% |
| GreenSky, Inc. | February 14, 2022 | 698,553 | 0.8% |
| GTY Technology Holdings Inc. | February 14, 2022 | 758,000 | 1.3% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.
Compare quarters
The following issues were detected while analyzing the report:
- The reported total value is incorrect (6114078000.0 != 6114078000000.0)
- The reported has been restated
- The reported has been amended
Export OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s holdings